Dispersible formulation of an antiinflammatory agent

Details for Australian Patent Application No. 2004222523 (hide)

Owner Pharmacia Corporation

Inventors Burns, John W.; Hallberg, John W.; Waldron, Niki A.; Watts, Jeffrey L.; Britten, Nancy J.

Agent Spruson & Ferguson

Pub. Number AU-A-2004222523

PCT Pub. Number WO2004/082588

Priority 60/456,325 20.03.03 US

Filing date 10 March 2004

Wipo publication date 30 September 2004

International Classifications

A61K 047/44 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/082588 Priority application(s): WO2004/082588

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222526-Nemorubicin as radiosensitizer in combination with radiation therapy against tumors

2004222518-Dispersible pharmaceutical composition for treatment of mastitis and otic disorders